Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
A recent study has shown that the Congenica platform demonstrated a superior role identifying the genetic causes of platelet-related bleeding disorders
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
New Funds to Drive Further Commercialisation of Rare and Inherited Cancer Applications and Expansion into Oncology, Wellness and Pharma Collaborations
Our plans for the future: a video message from our CEO and Chairman
Congenica CEO David Atkins PhD is joined by Chairman Andy Richards OBE in announcing the company's Series C fundraise.
The future of genotype-phenotype data standards to improve outcomes
Supporting Rare Disease Clinical Genomics: The future of genotype phenotype data standards & sharing for analysis to improve medical outcomes
Impact of the Deciphering Developmental Disorders Study
Poster at Rady's Children's Institute Frontiers in Paediatric Medicine Conference discusses the impact of the Deciphering Developmental Disorders study.
Congenica brings together Mastermind, DECIPHER and Sentieon in major product update
Congenica enables you to achieve 10X faster processing speeds, instantly access genetic evidence and minimize the risk of variants going undetected.